Marcus Maurer

Research interests

Publications

• The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update

  Allergy · 2022 · https://doi.org/10.1111/all.15214

• The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

  Allergy · 2021 · https://doi.org/10.1111/all.15090

• The global burden of chronic urticaria for the patient and society*

  British Journal of Dermatology · 2020 · https://doi.org/10.1111/bjd.19561

• Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta‐analysis

  Allergy · 2019 · https://doi.org/10.1111/all.14037

• The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

  Allergy · 2018 · https://doi.org/10.1111/all.13397

• The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update

  Allergy · 2018 · https://doi.org/10.1111/all.13384

• The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

  Dermatology Review · 2015 · https://doi.org/10.5114/dr.2015.51433

• Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

  Journal of Allergy and Clinical Immunology · 2015 · https://doi.org/10.1016/j.jaci.2015.08.034

• Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

  Journal of Investigative Dermatology · 2014 · https://doi.org/10.1038/jid.2014.306

• The EAACI / GA 2 LEN / EDF / WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

  Allergy · 2014 · https://doi.org/10.1111/all.12313

• Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control

  Journal of Allergy and Clinical Immunology · 2014 · https://doi.org/10.1016/j.jaci.2013.12.1076

• Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria

  New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1215372

• Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy

  Journal of Allergy and Clinical Immunology · 2013 · https://doi.org/10.1016/j.jaci.2013.05.013

• Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase

  Journal of Allergy and Clinical Immunology · 2011 · https://doi.org/10.1016/j.jaci.2011.04.038

• A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria

  Journal of Allergy and Clinical Immunology · 2011 · https://doi.org/10.1016/j.jaci.2011.06.010

• Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema

  New England Journal of Medicine · 2010 · https://doi.org/10.1056/nejmoa0906393

• Risk of first‐generation H 1 ‐antihistamines: a GA 2 LEN position paper

  Allergy · 2010 · https://doi.org/10.1111/j.1398-9995.2009.02325.x

• Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1

  Allergy · 2010 · https://doi.org/10.1111/j.1398-9995.2010.02496.x

• Epidemiology of urticaria: a representative cross-sectional population survey

  Clinical and Experimental Dermatology · 2010 · https://doi.org/10.1111/j.1365-2230.2010.03840.x

• EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria

  Allergy · 2009 · https://doi.org/10.1111/j.1398-9995.2009.02179.x

• EAACI/GA²LEN/EDF/WAO guideline: management of urticaria

  Allergy · 2009 · https://doi.org/10.1111/j.1398-9995.2009.02178.x

• How to assess disease activity in patients with chronic urticaria?

  Allergy · 2008 · https://doi.org/10.1111/j.1398-9995.2008.01726.x

• EAACI/GA2LEN/EDF guideline: management of urticaria

  Allergy · 2005 · https://doi.org/10.1111/j.1398-9995.2005.00962.x

• Macrophage inflammatory protein-1

  The International Journal of Biochemistry & Cell Biology · 2004 · https://doi.org/10.1016/j.biocel.2003.10.019

• What is the physiological function of mast cells?

  Experimental Dermatology · 2003 · https://doi.org/10.1111/j.0906-6705.2003.0109a.x

• Control of murine hair follicle regression (catagen) by TGF‐β1 in vivo

  The FASEB Journal · 2000 · https://doi.org/10.1096/fasebj.14.5.752

• A Comprehensive Guide for the Recognition and Classification of Distinct Stages of Hair Follicle Morphogenesis

  Journal of Investigative Dermatology · 1999 · https://doi.org/10.1046/j.1523-1747.1999.00740.x

• Mast cells as sentinels of innate immunity

  Current Opinion in Immunology · 1999 · https://doi.org/10.1016/s0952-7915(99)80010-7

Current projects

No projects listed.